SAMARITAN PHARMACEUTICALS INC·4

Sep 15, 7:47 PM ET

GREESON JANET 4

4 · SAMARITAN PHARMACEUTICALS INC · Filed Sep 15, 2008

Insider Transaction Report

Form 4
Period: 2008-09-11
GREESON JANET
DirectorChief Executive Officer
Transactions
  • Award

    Stock Optons (right to buy)

    2008-09-11+57,89557,895 total(indirect: NextGen LifeSciences, Inc.)
    Exercise: $0.19From: 2008-09-11Exp: 2010-09-11Common Stock (57,895 underlying)
  • Award

    Common Stock

    2008-09-11$0.20/sh+1,000,000$197,0001,000,000 total(indirect: NextGen LifeSciences DB Plan)
  • Disposition to Issuer

    Common Stock

    2008-09-11$0.20/sh1,000,000$197,000833,356 total(indirect: NextGen LifeSciences, Inc.)
Footnotes (1)
  • [F1]Option exercise price was equal or above the underlying stock price on grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION